Literature DB >> 11743972

In vitro stimulation of oxidative stress in cerebral cortex of rats by the guanidino compounds accumulating in hyperargininemia.

A T Wyse1, C S Bavaresco, M E Hagen, D Delwing, C M Wannmacher, C Severo Dutra-Filho, M Wajner.   

Abstract

Hyperargininemia is a metabolic disorder biochemically characterized by tissue accumulation of arginine and other guanidino compounds. Convulsions, lethargy and psychomotor delay or cognitive deterioration are predominant clinical features of this disease. Although neurologic symptoms predominate in this disorder, their pathophysiology is still unknown. In the present study we investigated the in vitro effects of arginine, N-acetylarginine, argininic acid and homoarginine on some oxidative stress parameters in rat brain in the hope to identify a possible mechanism for the brain damage in hyperargininemia. Chemiluminescence, total radical-trapping antioxidant potential (TRAP), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) activities were measured in the cerebral cortex of rats in the presence of various concentrations of these compounds. The results showed that all guanidino compounds tested significantly increased chemiluminescence and decreased TRAP at concentrations similar to those observed in the tissue of hyperargininemic patients. Furthermore, these compounds inhibited CAT and GSH-Px activities to varying extents, with GSH-Px activity being more susceptible to their action. In turn, argininic acid inhibited all enzyme activities, and its main action was also directed towards GSH-Px. The results suggest that oxidative stress caused by guanidino compounds may be involved in the brain dysfunction amongst other potential pathophysiological mechanisms observed in hyperargininemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11743972     DOI: 10.1016/s0006-8993(01)03197-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

Review 1.  Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency.

Authors:  Fernando Scaglia; Brendan Lee
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

2.  Brain Na+,K(+)-ATPase inhibition induced by arginine administration is prevented by vitamins E and C.

Authors:  Caren S Bavaresco; Thiago Calcagnotto; Bárbara Tagliari; Daniela Delwing; Marcelo L Lamers; Clóvis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

3.  Recent Advances in Understanding of Alzheimer's Disease Progression through Mass Spectrometry-Based Metabolomics.

Authors:  Jericha Mill; Lingjun Li
Journal:  Phenomics       Date:  2022-02-22

4.  Erythrocyte sphingolipid species as biomarkers of Alzheimer's disease.

Authors:  Jericha Mill; Vihar Patel; Ozioma Okonkwo; Lingjun Li; Thomas Raife
Journal:  J Pharm Anal       Date:  2021-07-14

5.  Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders.

Authors:  Lindsay C Burrage; Lillian Thistlethwaite; Bridget M Stroup; Qin Sun; Marcus J Miller; Sandesh C S Nagamani; William Craigen; Fernando Scaglia; V Reid Sutton; Brett Graham; Adam D Kennedy; Aleksandar Milosavljevic; Brendan H Lee; Sarah H Elsea
Journal:  Genet Med       Date:  2019-01-23       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.